Ovid Therapeutics: Buy Next-Gen GABA-Aminotransferase Inhibitor OV329 And TSC/IS Expansions

OV329Neutral

AI Analysis

Summary

The article appears to be a headline recommendation regarding Ovid Therapeutics and its GABA-aminotransferase inhibitor OV329, with mention of TSC and infantile spasms expansion, but contains insufficient detail for substantive analysis.

Importance:1/10

Sentiment:

0.00

GABA-aminotransferase inhibitorpipelinerare disease

Related Companies

$INTI

Read the original article

Published by Seeking Alpha Healthcare on July 7, 2026 8:20 PM

Read Original